Become a Founding Member for $999 a year, locked for life

    Claim a seat
    MavenlyMavenly

    § Federal grant opportunity · RFA-FD-27-001

    Research on Complex Generics

    Food and Drug Administration is accepting applications for Research on Complex Generics. The deadline is December 14, 2026 and the published award range is $0 – $2.5M.

    Key facts

    Funder
    Food and Drug Administration
    Application deadline
    December 14, 2026
    Award range
    $0 – $2.5M
    Eligibility
    other
    Geography
    United States
    Focus areas
    Agriculture, Consumer Protection, Food And Nutrition, Health
    Opportunity number
    RFA-FD-27-001

    Program overview

    The purpose of this funding opportunity is to expand access for Americans to high-quality, safe, and effective generic medicines, and help reduce the risk of drug shortages through a more competitive and multi-sourced generic drug market in the U.S., congruent with FDA’s Public Health Pillars.

    How to apply

    1. Confirm your organization meets the eligibility criteria above.
    2. Read the full funding opportunity announcement from Food and Drug Administration.
    3. Draft your narrative against the funder's stated priorities and review criteria.
    4. Submit before December 14, 2026, allowing time for registration and validation.

    View the official funding announcement

    Find every grant your organization qualifies for

    Mavenly scores this opportunity against your mission, geography, and funding history — then drafts the proposal with you and tracks the deadline through submission and reporting.